Rational Use of Antimicrobial Agents and Investigational Drugs for the Management of COVID-19
February 2, 2022
No Comments
The DOH reiterates the rational use of antimicrobials and investigational drugs for COVID-19 management
Adjustments in Maximum Retail Price (MRP) Regulation of Certain Medicines that are Covered by Executive Order No. 155 Pursuant to Exemption from Value Added Tax (VAT)
February 10, 2022
No Comments
DOH informs the public of the adjustments in the Maximum Retail Price (MRP) of certain medicines that are covered by EO 155
Conduct of the 2022 Antimicrobial Stewardship (AMS) Blended Learning Framework Program for Hospitals through Online Platforms
February 21, 2022
No Comments
The DOH Pharmaceutical Division continues to cascade the National Antimicrobial Stewardship (AMS) training program for hospitals through the blended learning framework
Updated Suggested Retail Price (SRPs) for Emergency Essential Medicines and Medical Devices due to the Coronavirus Disease 2019 (COVID-19) Health Event as of January 19, 2022
February 28, 2022
No Comments
DOH adds Molnupiravir in the Updated SRP List
List of VAT-exempt Drugs and Vaccines Prescribed and Directly Used for COVID-19 Treatment as of 01-22-2022
September 1, 2021
No Comments
The DOH issues list of VAT-exempt drugs and vaccines prescribed and used for COVID-19 management